Ohta A - Search Results

1

The antihypoxia-adenosinergic pathogenesis as a result of collateral damage by overactive immune cells.

Hatfield S, Belikoff B, Lukashev D, Sitkovsky M, Ohta A. Hatfield S, et al. Among authors: ohta a. J Leukoc Biol. 2009 Sep;86(3):545-8. doi: 10.1189/jlb.0908577. Epub 2009 Jun 29. J Leukoc Biol. 2009. PMID: 19564571 Free PMC article. Review.

2

The 'danger' sensors that STOP the immune response: the A2 adenosine receptors?

Sitkovsky MV, Ohta A. Sitkovsky MV, et al. Among authors: ohta a. Trends Immunol. 2005 Jun;26(6):299-304. doi: 10.1016/j.it.2005.04.004. Trends Immunol. 2005. PMID: 15922945

3

1,3,7-trimethylxanthine (caffeine) may exacerbate acute inflammatory liver injury by weakening the physiological immunosuppressive mechanism.

Ohta A, Lukashev D, Jackson EK, Fredholm BB, Sitkovsky M. Ohta A, et al. J Immunol. 2007 Dec 1;179(11):7431-8. doi: 10.4049/jimmunol.179.11.7431. J Immunol. 2007. PMID: 18025187

4

Hypoxia-adenosinergic immunosuppression: tumor protection by T regulatory cells and cancerous tissue hypoxia.

Sitkovsky MV, Kjaergaard J, Lukashev D, Ohta A. Sitkovsky MV, et al. Among authors: ohta a. Clin Cancer Res. 2008 Oct 1;14(19):5947-52. doi: 10.1158/1078-0432.CCR-08-0229. Clin Cancer Res. 2008. PMID: 18829471 Review.

5

The adenosinergic immunomodulatory drugs.

Ohta A, Sitkovsky M. Ohta A, et al. Curr Opin Pharmacol. 2009 Aug;9(4):501-6. doi: 10.1016/j.coph.2009.05.005. Epub 2009 Jun 17. Curr Opin Pharmacol. 2009. PMID: 19539527 Free PMC article. Review.

6

Methylxanthines, inflammation, and cancer: fundamental mechanisms.

Ohta A, Sitkovsky M. Ohta A, et al. Handb Exp Pharmacol. 2011;(200):469-81. doi: 10.1007/978-3-642-13443-2_19. Handb Exp Pharmacol. 2011. PMID: 20859809 Review.

7

Genetic deletion of the HIF-1α isoform I.1 in T cells enhances antibacterial immunity and improves survival in a murine peritonitis model.

Georgiev P, Belikoff BG, Hatfield S, Ohta A, Sitkovsky MV, Lukashev D. Georgiev P, et al. Among authors: ohta a. Eur J Immunol. 2013 Mar;43(3):655-66. doi: 10.1002/eji.201242765. Epub 2013 Jan 31. Eur J Immunol. 2013. PMID: 23208786 Free PMC article.

8

Targeting the hypoxia-adenosinergic signaling pathway to improve the adoptive immunotherapy of cancer.

Sitkovsky M, Ohta A. Sitkovsky M, et al. Among authors: ohta a. J Mol Med (Berl). 2013 Feb;91(2):147-55. doi: 10.1007/s00109-013-1001-9. Epub 2013 Jan 20. J Mol Med (Berl). 2013. PMID: 23334369 Free PMC article. Review.

9

Hostile, hypoxia-A2-adenosinergic tumor biology as the next barrier to overcome for tumor immunologists.

Sitkovsky MV, Hatfield S, Abbott R, Belikoff B, Lukashev D, Ohta A. Sitkovsky MV, et al. Among authors: ohta a. Cancer Immunol Res. 2014 Jul;2(7):598-605. doi: 10.1158/2326-6066.CIR-14-0075. Cancer Immunol Res. 2014. PMID: 24990240 Free PMC article. Review.

10

Systemic oxygenation weakens the hypoxia and hypoxia inducible factor 1α-dependent and extracellular adenosine-mediated tumor protection.

Hatfield SM, Kjaergaard J, Lukashev D, Belikoff B, Schreiber TH, Sethumadhavan S, Abbott R, Philbrook P, Thayer M, Shujia D, Rodig S, Kutok JL, Ren J, Ohta A, Podack ER, Karger B, Jackson EK, Sitkovsky M. Hatfield SM, et al. Among authors: ohta a. J Mol Med (Berl). 2014 Dec;92(12):1283-92. doi: 10.1007/s00109-014-1189-3. Epub 2014 Aug 15. J Mol Med (Berl). 2014. PMID: 25120128 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

908 results

Search Page

Filters